In the Wall Street Journal on March 23 David Armstrong writes in his Health Blog that the Journal of the American Medical Association (JAMA): says it is adopting a new policy under which anyone…
In an op-ed in the Des Moines Register (3/20) Joel Olah, executive director of aging resources of central Iowa, wrote, Earlier this year, the U.S. Supreme Court decided in favor of…
The Legal Intelligencer (2/11, Elliot-Engel) reports, A month before a pharmaceutical class action was set for trial, a Philadelphia judge decertified the class of users of an epilepsy and neuralgia…
Did you know that drug companies pay doctors money? The payments cover a range of activities such as doctor’s speaking engagements, clinical trials, payments to institutions like Universities where…
In the second installment of an interview with President Barack Obama, Matt Lauer on the NBC Today Show (2/2, 7:13 a.m. EST) noted the massive peanut butter products recall traced back to a Georgia…
The AP (1/21, Loven) reports the one of President Barack Obama’s first acts Tuesday was to put the brakes on all pending regulations that the Bush administration tried to push through in its waning…
A recent court decision holds that generic drug manufacturers cannot use federal preemption to avoid liability for failing to warn of their drugs’ dangers. The court in Kellogg v. Wyeth held, as…
Arthur Bryant is a brilliant attorney and constitutional scholar. He knows. He knows that as the American public grapples with the Wall Street financial crisis, fears about their jobs and their…
The AP (1/12) reports, An internal watchdog finds that financial conflicts involving outside researchers who test experimental drugs often remain hidden, and missing information, loopholes, and weak…
ScienceDaily (Dec. 27, 2008) — For patients on dialysis, taking medications to reduce levels of the mineral phosphorus in the blood may reduce the risk of death by 25 to 30 percent,…
The Dow Jones (12/31, Dooren) reported, The Food and Drug Administration said Wednesday Celgene Corp. (CELG) added an additional warning to its blood-clot busting drug Innohep stating it could…
December 29, 2008 Drug Companies and Doctors The latest New York Review of Books (Jan. 15, 2009 issue) contains an interesting article by Marcia Angell, former Editor-in-Chief of the New England…